Appeals Court Vacates $177M Covidien Award In Spat With Johnson & Johnson

A federal appeals court today overturned the $177 million awarded to Covidien (NYSE:COV) last year in its long-running patent infringement battle with Johnson & Johnson's (NYSE:JNJ) Ethicon Endo-Surgery subsidiary.

Judge Janet Bond Arterton had ruled that Ethicon Endo-Surgery infringed 6 claims in 3 patents held by Covidien's corporate predecessors, Tyco Healthcare and U.S. Surgical Corp., with products including its Autosonix and LCS ultrasonic scalpels (Covidien's competing products include its Harmonic Shears, according to the court documents).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC